Basic Information
Clopidogrel/Acetylsalicylic acid Zentiva (previously DuoCover)
Regulatory Information
EMEA/H/C/001144
Authorised
March 14, 2010
22
November 13, 2019
Company Information
France
54 rue La Boétie F-75008 Paris
SANOFI-AVENTIS GROUPE
Active Substances Detail
EMA Resources
Detailed Information
Therapeutic Indication
### Therapeutic indication - Acute Coronary Syndrome - Myocardial Infarction
Overview Summary
This document is a summary of the European Public Assessment Report (EPAR) for Clopidogrel/Acetylsalicylic acid Zentiva. It explains how the Committee for Medicinal Products for Human Use (CHMP) assessed the medicine to reach its opinion in favour of granting a marketing authorisation and its recommendations on the conditions of use for Clopidogrel/Acetylsalicylic acid Zentiva.